26 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07958 | Compound 2a | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 31.64 ± 1.30 µM |
| dbacp07959 | Compound 2a | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 20.37 ± 1.36 µM |
| dbacp07960 | Compound 2b | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 32.58 ± 1.50 µM |
| dbacp07961 | Compound 2b | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 15.80 ± 1.66 µM |
| dbacp07962 | Compound 2c | Structure in scheme 1 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 35.52 ± 1.83 µM |
| dbacp07963 | Compound 3a | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 26.01 ± 2.35 µM |
| dbacp07964 | Compound 3b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 25.33 ± 1.18 µM |
| dbacp07965 | Compound 3b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 13.54 ± 1.45 µM |
| dbacp07966 | Compound 3c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 29.55 ± 2.06 µM |
| dbacp07967 | Compound 3c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 26.64 ± 1.85 µM |
| dbacp07968 | Compound 4a | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 11.59 ± 2.70 µM |
| dbacp07969 | Compound 4b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 10.45 ± 1.33 µM |
| dbacp07970 | Compound 4b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 10.25 ± 2.20 µM |
| dbacp07971 | Compound 4c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 29.15 ± 1.39 µM |
| dbacp07972 | Compound 4c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 18.84 ± 1.47 µM |
| dbacp07973 | Compound 5a | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 12.67 ± 2.40 µM |
| dbacp07974 | Compound 5a | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 11.19 ± 1.95 µM |
| dbacp07975 | Compound 5b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 11.32 ± 1.15 µM |
| dbacp07976 | Compound 5b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 10.09 ± 2.05 µM |
| dbacp07977 | Compound 5c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 9.41 ± 1.25 µM |
| dbacp07978 | Compound 5c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 7.53 ± 1.33 µM |
| dbacp07979 | Compound 6a | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 11.83 ± 1.62 µM |
| dbacp07980 | Compound 6a | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 12.44 ± 1.3 µM |
| dbacp07981 | Compound 6b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | MCF-7 | Breast Cancer | IC50 = 10.87 ± 1.10 µM |
| dbacp07982 | Compound 6b | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 11.53 ± 1.70 µM |
| dbacp07983 | Compound 6c | Structure in scheme 2 | Synthetic | 5c inhibits cancer via kinase blockade | Not Available | HepG-2 | Liver Cancer | IC50 = 12.07 ± 1.68 µM |